Status:
COMPLETED
Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention
Lead Sponsor:
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The aim of this study is to determine whether postprandial hyperglycaemia plays an important role in oxidative stress phenomena and influences their harmful effects on the arterial wall. 25 type 1 di...
Eligibility Criteria
Inclusion
- Type 1 Diabetes
- treaties by basal / bolus with a ultra rapid analogue or a pump with a ultra rapid analogue
- Adults between 18 and 50 years old
- Patients practicing FIT
- Written informed consent obtained prior to enrollment in the study
- HbA1c ≤ 8%
Exclusion
- Diabetes other than DT1
- Complications: coronary or peripheral arteriopathy
- Pathologies being able to interfere with the study: HTA, dyslipidemia, nicotinism, inflammatory , cancerous pathology…
- Psychiatric pathologies incompatible with the study
- Pregnancy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00934336
Start Date
November 1 2008
End Date
April 1 2011
Last Update
August 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH sud francilien
Corbeil-Essonnes, France, 91106